BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to H1299 cell line is 379
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | MACs and IF staining followed by qRT-PCR | NA | 0.56 | 0.1739 | 31819528 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by qPCR | NA | 0.56 | 0.1739 | 24008862 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.56 | 0.1739 | 33980809 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and Western Blotting | NA | 0.56 | 0.1739 | 31871777 |
| PRDX6 | 16753 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | IF staining followed by Western Blotting | NA | 0.52 | 0.0042 | 31819528 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | IF staining and Western Blotting followed by SFA | NA | 0.52 | 0.5695 | 35278461 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.52 | 0.5695 | 33783940 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 34873829 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 30555330 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs and Western Blotting | NA | 0.52 | 0.5695 | 27542268 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by Western Blotting and SFA | NA | 0.52 | 0.5695 | 24838270 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by qPCR | NA | 0.52 | 0.5695 | 24008862 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and qRT-PCR | NA | 0.52 | 0.5695 | 30816208 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and FACs | NA | 0.52 | 0.5695 | 25669973 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 33980809 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by CFA and Western Blotting | NA | 0.52 | 0.5695 | 32637578 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 33125096 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | FACs for CSC marker followed by qRT-PCR | NA | 0.52 | 0.5695 | 33550205 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR and SFA | NA | 0.52 | 0.5695 | 34681614 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 34832951 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and SFA | NA | 0.52 | 0.5695 | 29144562 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR | NA | 0.52 | 0.5695 | 25906011 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Gefitinib | SFA and CFA followed by RT-PCR | NA | 0.52 | 0.5695 | 28850563 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Regorafenib | SFA and CFA followed by RT-PCR | NA | 0.52 | 0.5695 | 28850563 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Sorafenib | SFA and CFA followed by RT-PCR | NA | 0.52 | 0.5695 | 28850563 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qPCR | NA | 0.52 | 0.5695 | 26675547 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 25279705 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 32051483 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 32401390 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 32655321 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.5695 | 25735977 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.5695 | 27556038 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.5695 | 29651165 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 31871777 |
| SOX9 | 11204 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | IF staining and Western Blotting followed by SFA | NA | 0.52 | 0.0244 | 35278461 |
| VTCN1 | 28873 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | IF staining and Western Blotting followed by SFA | NA | 0.52 | 0.0021 | 35278461 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.684 | 28431267 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR followed by FACs | NA | 0.48 | 0.684 | 25906011 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.684 | 33980809 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.684 | 23583374 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.684 | 26518146 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.684 | 27836540 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.684 | 28198062 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | ALDEFLUOR assay followed by FACs | NA | 0.48 | 0.684 | 24595209 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | ALDEFLUOR assay followed by FACs and CFA | NA | 0.48 | 0.684 | 27542268 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | CFA followed by IF staining | NA | 0.48 | 0.684 | 25831148 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.684 | 33468994 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qPCR | NA | 0.48 | 0.684 | 26675547 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.684 | 32051483 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | ALDEFLUOR assay followed by CFA | NA | 0.48 | 0.684 | 33550205 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | ALDEFLUOR assay followed by SFA | NA | 0.48 | 0.684 | 33783940 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 33539684 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 34546848 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Paclitaxel | ALDEFLUOR assay followed by SFA | NA | 0.48 | 0.684 | 24278179 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by CFA | NA | 0.48 | 0.684 | 21827695 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by SFA | NA | 0.48 | 0.684 | 24091605 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Gefitinib | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 28850563 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Sorafenib | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 28850563 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 30555330 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 32401390 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 32612672 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.1135 | 30555330 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by CFA and Western Blotting | NA | 0.48 | 0.1135 | 32637578 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | SFA followed by qRT-PCR | NA | 0.48 | 0.1135 | 25279705 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.1135 | 21124918 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 1 | 28431267 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by Western Blotting and SFA | NA | 0.48 | 1 | 24838270 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by IHC staining and SFA | NA | 0.48 | 1 | 21124918 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and qRT-PCR | NA | 0.48 | 1 | 30816208 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and RT-PCR | NA | 0.48 | 1 | 29651165 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and FACs | NA | 0.48 | 1 | 25669973 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 1 | 33980809 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | Western Blotting followed by SFA | NA | 0.48 | 1 | 35278461 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by CFA and Western Blotting | NA | 0.48 | 1 | 32637578 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 1 | 27836540 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 1 | 28198062 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 1 | 33125096 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | Western Blotting | NA | 0.48 | 1 | 29552200 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 1 | 34832951 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | FACs followed by CFA | NA | 0.48 | 1 | 33550205 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 1 | 24595209 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 1 | 31585300 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by SFA | NA | 0.48 | 1 | 24091605 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by SFA | NA | 0.48 | 1 | 29144562 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs | NA | 0.48 | 1 | 25965829 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs | NA | 0.48 | 1 | 30555330 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | SFA followed by FACs | NA | 0.48 | 1 | 32655321 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and SFA followed by FACs and Tumorigenicity assay | NA | 0.48 | 1 | 20949018 |
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.211 | 33539684 |
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | FACs followed by SFA and Tumorigenicity assay | NA | 0.48 | 0.211 | 25279705 |
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Tumorigenicity assay and FACs | NA | 0.48 | 0.211 | 23820871 |
| IKZF3 | 13178 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and Western Blotting followed by SFA and Tumorigenicity assay | NA | 0.48 | 0.0032 | 30816208 |
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0891 | 34873829 |
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0891 | 30555330 |
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR | NA | 0.48 | 0.0891 | 25906011 |
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.0891 | 29651165 |
| MIR19A | 31574 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0064 | 28431267 |
| MIR19B1 | 31575 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0042 | 28431267 |
| MYC | 7553 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.1304 | 30555330 |
| MYC | 7553 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.1304 | 33980809 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 28431267 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 30555330 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs and Western Blotting | NA | 0.48 | 0.5461 | 27542268 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by qPCR | NA | 0.48 | 0.5461 | 24008862 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and qRT-PCR | NA | 0.48 | 0.5461 | 30816208 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and FACs | NA | 0.48 | 0.5461 | 25669973 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 33980809 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by CFA and Western Blotting | NA | 0.48 | 0.5461 | 32637578 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 27836540 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 28198062 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 33125096 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 33468994 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 34832951 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by and qRT-PCR | NA | 0.48 | 0.5461 | 29620443 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qPCR | NA | 0.48 | 0.5461 | 26675547 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 32051483 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 32401390 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 32612672 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 32655321 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.5461 | 25735977 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.5461 | 27556038 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.5461 | 29651165 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 31871777 |
| NOTCH1 | 7881 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0477 | 30555330 |
| NOTCH1 | 7881 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.0477 | 29651165 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.6448 | 33783940 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 33539684 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 34873829 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 28431267 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 30555330 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs and Western Blotting | NA | 0.48 | 0.6448 | 27542268 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by IF staining | NA | 0.48 | 0.6448 | 21124918 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by qPCR | NA | 0.48 | 0.6448 | 24008862 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and qRT-PCR | NA | 0.48 | 0.6448 | 30816208 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and FACs | NA | 0.48 | 0.6448 | 25669973 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 33980809 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | Western Blotting | NA | 0.48 | 0.6448 | 34803670 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by CFA and Western Blotting | NA | 0.48 | 0.6448 | 32637578 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 23583374 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 27836540 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 27836540 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 28198062 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 33125096 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR and SFA | NA | 0.48 | 0.6448 | 34681614 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 33468994 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 34832951 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and SFA | NA | 0.48 | 0.6448 | 29144562 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR | NA | 0.48 | 0.6448 | 22300949 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Gefitinib | SFA and CFA followed by RT-PCR | NA | 0.48 | 0.6448 | 28850563 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Regorafenib | SFA and CFA followed by RT-PCR | NA | 0.48 | 0.6448 | 28850563 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Sorafenib | SFA and CFA followed by RT-PCR | NA | 0.48 | 0.6448 | 28850563 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qPCR | NA | 0.48 | 0.6448 | 26675547 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 25279705 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 32051483 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 32401390 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 32612672 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 32655321 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.6448 | 25735977 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.6448 | 27556038 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 31871777 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and SFA followed by FACs and Tumorigenicity assay | NA | 0.48 | 0.6448 | 20949018 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.7582 | 33783940 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 33539684 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 28431267 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by FACs and qPCR | NA | 0.48 | 0.7582 | 26675547 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and Western Blotting | NA | 0.48 | 0.7582 | 28198062 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting and FACs | NA | 0.48 | 0.7582 | 33125096 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs and IF staining | NA | 0.48 | 0.7582 | 31819528 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and qRT-PCR | NA | 0.48 | 0.7582 | 30816208 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and RT-PCR | NA | 0.48 | 0.7582 | 29651165 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and FACs | NA | 0.48 | 0.7582 | 25669973 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 33980809 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | Western Blotting | NA | 0.48 | 0.7582 | 34803670 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 23583374 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 26518146 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 27836540 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | CFA followed by IF staining | NA | 0.48 | 0.7582 | 25831148 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by FACs | NA | 0.48 | 0.7582 | 30880491 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.7582 | 33468994 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.7582 | 34832951 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and SFA | NA | 0.48 | 0.7582 | 29144562 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR | NA | 0.48 | 0.7582 | 25906011 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.7582 | 32051483 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.7582 | 23370278 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.7582 | 33959615 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.7582 | 35337095 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA and FACs | NA | 0.48 | 0.7582 | 33631674 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.7582 | 24440048 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.7582 | 24595209 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.7582 | 27542268 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs | NA | 0.48 | 0.7582 | 31585300 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by SFA | NA | 0.48 | 0.7582 | 25735977 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by SFA | NA | 0.48 | 0.7582 | 29144562 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | FACs followed by SFA and Tumorigenicity assay | NA | 0.48 | 0.7582 | 25279705 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | MACs followed by SFA and Tumorigenicity assay | NA | 0.48 | 0.7582 | 24008862 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs | NA | 0.48 | 0.7582 | 25965829 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and SFA followed by FACs and Tumorigenicity assay | NA | 0.48 | 0.7582 | 20949018 |
| SHH | 10848 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0201 | 30555330 |
| SUZ12 | 17101 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 25279705 |
| TGIF2 | 15764 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SP assay and Western Blotting followed by qRT-PCR and SFA | NA | 0.48 | 0.0021 | 31871777 |
| FOXF1 | 3809 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR and IF staining followed by SFA and Tumorigenicity assay | NA | 0.44 | 0.0032 | 32319573 |
| MYH9 | 7579 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and Western Blotting | NA | 0.4 | 0.0064 | 34635641 |
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and RT-PCR | NA | 0.32 | 0.0583 | 29651165 |
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA and FACs | NA | 0.32 | 0.0583 | 33631674 |
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | SFA followed by FACs | NA | 0.32 | 0.0583 | 32655321 |
| ALK | 427 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA and FACs followed by RT-PCR and Migration assay | NA | 0.32 | 0.0021 | 25735977 |
| CACNA2D1 | 1399 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs followed by qPCR and SFA | NA | 0.32 | 0.0064 | 30464601 |
| CXCR4 | 2561 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR and FACs | NA | 0.32 | 0.0498 | 25669973 |
| EML4 | 1316 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA and FACs followed by RT-PCR and Migration assay | NA | 0.32 | 0.0042 | 25735977 |
| MIR2861 | 38221 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.0032 | 29620443 |
| MIR5100 | 43540 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR followed by FACs and SFA | NA | 0.32 | 0.0011 | 29144562 |
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0604 | 33980809 |
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Docetaxel | RT-PCR | NA | 0.28 | 0.0604 | 28959367 |
| ABCC1 | 51 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0212 | 33980809 |
| CAMK2G | 1463 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting and Tumorigenicity assay | NA | 0.28 | 0.0021 | 25965829 |
| CCND1 | 1582 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 33980809 |
| CLOCK | 2082 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0021 | 33125096 |
| CTNNB1 | 2514 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0647 | 33980809 |
| CTNNB1 | 2514 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0647 | 27836540 |
| CTNNB1 | 2514 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | Western Blotting | NA | 0.28 | 0.0647 | 31819528 |
| CTNNB1 | 2514 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.0647 | 25669973 |
| LGR5 | 4504 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by CFA and Western Blotting | NA | 0.28 | 0.0753 | 32637578 |
| WNT1 | 12774 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | Cisplatin | Western Blotting | NA | 0.28 | 0.0074 | 31819528 |
| CD34 | 1662 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0053 | 30981768 |
| LIN28A | 15986 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | BME based 3D culture followed by SFA and qRT-PCR | Up | 0.2 | 0.0138 | 34277782 |
| MACsC1-AS1 | 41257 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0011 | 32401390 |
| MIR410 | 32065 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | qRT-PCR followed by SFA and Tumorigenicity assay | NA | 0.2 | 0.0011 | 28076327 |
| MIRLET7C | 31480 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | BME based 3D culture followed by SFA and qRT-PCR | Down | 0.2 | 0.0042 | 34277782 |
| MIRLET7F1 | 31483 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | BME based 3D culture followed by SFA and qRT-PCR | Down | 0.2 | 0.0053 | 34277782 |
| MIRLET7G | 31485 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | BME based 3D culture followed by SFA and qRT-PCR | Down | 0.2 | 0.0032 | 34277782 |
| NDRG1 | 7679 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR and Tumorigenicity assay | NA | 0.2 | 0.0064 | 28456659 |
| SLC22A2 | 10966 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0011 | 29651165 |
| SMO | 11119 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0212 | 25669973 |
| USP29 | 18563 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | RT-PCR followed by Tumorigenicity assay | NA | 0.2 | 0.0011 | 32968046 |
| ZNF322 | 23640 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0011 | 30258097 |
| CD24 | 1645 | LTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 30555330 |
| ABCC5 | 56 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23820871 |
| ACTN4 | 166 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 23820871 |
| ADRB2 | 286 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| AGPAT3 | 326 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| AKAP12 | 370 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 23820871 |
| AKT2 | 392 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| AKT2 | 392 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| ANK3 | 494 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| ANTXR1 | 21014 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| AXL | 905 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| BICC1 | 19351 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| BID | 1050 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| BIN1 | 1052 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| BLMH | 1059 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 23820871 |
| BST2 | 1119 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23820871 |
| C18ORF54 | 13796 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| C19ORF33 | 16668 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| C4orf46 | 27320 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| CALB2 | 1435 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23820871 |
| CALM1 | 1442 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| CCDC97 | 28289 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| CD200 | 7203 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| CD59 | 1689 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23820871 |
| CDH2 | 1759 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 23820871 |
| CENPB | 1852 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| CNKSR2 | 19701 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| CPM | 2311 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 23820871 |
| DACH1 | 2663 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| DHFR | 2861 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| DIDO1 | 2680 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| DMPK | 2933 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| DPEP3 | 23029 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| EFHD2 | 28670 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| EGR1 | 3238 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 23820871 |
| EML2 | 18035 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| ERCC1 | 3433 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| ERCC6 | 3438 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| FAM110C | 33340 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| FGD4 | 19125 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 23820871 |
| FHL2 | 3703 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23820871 |
| FUT9 | 4020 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| GDA | 4212 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| HAUS5 | 29130 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| HBP1 | 23200 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| HELLS | 4861 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| HILPDA | 28859 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23820871 |
| HNRPUL1 | 17011 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| HS3ST3A1 | 5196 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| IGFLR1 | 23620 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| IL7 | 6023 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| IMPAD1 | 26019 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| JPH1 | 14201 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| KDELR3 | 6306 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| KHDRBS1 | 18116 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| KLHDC3 | 20704 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| KRT8 | 6446 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 23820871 |
| LHX6 | 21735 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| LSM14A | 24489 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| LSR | 29572 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| LSS | 6708 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| LYN | 6735 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| MAST3 | 19036 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| MED22 | 11477 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| MFAP5 | 29673 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| MICAL2 | 24693 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| MIR200A | 31578 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 33959615 |
| MIR208A | 31585 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 33959615 |
| MIR221 | 31601 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 33959615 |
| MIR222 | 31602 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 33959615 |
| MIR26B | 31612 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 33959615 |
| MIR26B | 31612 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 33959615 |
| MIR34C | 31637 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 33959615 |
| MIR501 | 32135 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 33959615 |
| MIR504 | 32139 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 33959615 |
| NDFIP2 | 18537 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| NECTIN2 | 9707 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| NOL3 | 7869 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| NRARP | 33843 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| NRG1 | 7997 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| NRN1 | 17972 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| NUAK1 | 14311 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| NXF2B | 23984 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| OPN3 | 14007 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| OSMR | 1355 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| PAF1 | 25459 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| PAG1 | 30043 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| PCDH7 | 8659 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| PCMTD1 | 30483 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| PDCD5 | 8764 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| PDLIM4 | 16501 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| PEPD | 8840 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| PHLDB2 | 29573 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| PKP4 | 9026 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| POLR1G | 24219 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| POLR2D | 9191 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| POU4F1 | 9218 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| PPIF | 9259 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| PRKCA | 9393 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| PRSS23 | 14370 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| PTHLH | 9607 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 23820871 |
| RBM42 | 28117 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| RBP7 | 30316 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| RFLNA | 27051 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| RHBDF1 | 20561 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| RIMKLA | 28725 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| RNASEH2C | 24116 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| RRAGA | 16963 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| RTL10 | 26112 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| RYBP | 10480 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| SAMD4B | 25492 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| SARS2 | 17697 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| SEPHS1 | 19685 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| SHKBP1 | 19214 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| SLC7A2 | 11060 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| SLITRK5 | 20295 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| SMG9 | 25763 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| SMG9 | 25763 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| SOBP | 29256 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| SOCS2 | 19382 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23820871 |
| SPP1 | 11255 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23820871 |
| SUPT5H | 11469 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| SYNCRIP | 16918 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 23820871 |
| SYNGR3 | 11501 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| TDRD12 | 25044 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| TFPI2 | 11761 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 23820871 |
| THBS1 | 11785 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| TM4SF1 | 11853 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23820871 |
| TM4SF18 | 25181 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| TMEM245 | 1363 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| TMEM45A | 25480 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23820871 |
| TMSB15A | 30744 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| TNFRSF25 | 11910 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| TNPO2 | 19998 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23820871 |
| TOMM40 | 18001 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| TPM1 | 12010 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23820871 |
| TRPM6 | 17995 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| UBA2 | 30661 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23820871 |
| UQCR10 | 30863 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| VAMP1 | 12642 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23820871 |
| XRCC3 | 12830 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| ZFHX4 | 30939 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |
| ZNF428 | 20804 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23820871 |
| ZNF585A | 26305 | HTM | Non Small Cell Lung Cancer | Carcinoma | H1299 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23820871 |